0000950123-23-008457.txt : 20230907
0000950123-23-008457.hdr.sgml : 20230907
20230907160603
ACCESSION NUMBER: 0000950123-23-008457
CONFORMED SUBMISSION TYPE: 13F-HR/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230907
DATE AS OF CHANGE: 20230907
EFFECTIVENESS DATE: 20230907
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MPM ASSET MANAGEMENT LLC
CENTRAL INDEX KEY: 0001263048
IRS NUMBER: 043351032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-13379
FILM NUMBER: 231242293
BUSINESS ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR/A
1
primary_doc.xml
X0202
13F-HR/A
LIVE
0001263048
XXXXXXXX
06-30-2023
06-30-2023
true
1
RESTATEMENT
false
MPM ASSET MANAGEMENT LLC
399 BOYLSTON STREET, SUITE 1100
BOSTON
MA
02116
13F HOLDINGS REPORT
028-13379
000148467
801-106989
N
Brendan Furey
Chief Compliance Officer
(617) 425-9222
/s/Brendan Furey
Boston
MA
09-06-2023
0
8
203918112
false
INFORMATION TABLE
2
26173.xml
INFORMATION TABLE FOR FORM 13F
Adaptimmune Therapeutics plc
Common
00653A107
5815569
6287101
SH
SOLE
6287101
0
0
Dyne Therapeutics, Inc.
Common
26818M108
55702159
4951303
SH
SOLE
4951303
0
0
Entrada Therapeutics, Inc.
Common
29384C108
67006370
4425784
SH
SOLE
4425784
0
0
Harpoon Therapeutics, Inc.
Common
41358P106
2223285
3131388
SH
SOLE
3131388
0
0
iTeos Therapeutics, Inc.
Common
46565G104
36261513
2738785
SH
SOLE
2738785
0
0
Oncorus, Inc.
Common
68236R103
115403
2849464
SH
SOLE
2849464
0
0
Repare Therapeutics, Inc.
Common
760273102
23727089
2242636
SH
SOLE
2242636
0
0
Werewolf Therapeutics, Inc.
Common
95075A107
13066725
4284172
SH
SOLE
4284172
0
0